511 related articles for article (PubMed ID: 18199132)
1. The impact of Type 2 diabetes and microalbuminuria on future cardiovascular events in patients with clinically manifest vascular disease from the Second Manifestations of ARTerial disease (SMART) study.
Soedamah-Muthu SS; Visseren FL; Algra A; van der Graaf Y;
Diabet Med; 2008 Jan; 25(1):51-7. PubMed ID: 18199132
[TBL] [Abstract][Full Text] [Related]
2. Diabetic retinopathy is associated with an increased incidence of cardiovascular events in Type 2 diabetic patients.
Targher G; Bertolini L; Zenari L; Lippi G; Pichiri I; Zoppini G; Muggeo M; Arcaro G
Diabet Med; 2008 Jan; 25(1):45-50. PubMed ID: 18199131
[TBL] [Abstract][Full Text] [Related]
3. Microalbuminuria presents the same vascular risk as overt CVD in type 2 diabetes.
Gimeno-Orna JA; Molinero-Herguedas E; Sánchez-Vaño R; Lou-Arnal LM; Boned-Juliani B; Castro-Alonso FJ
Diabetes Res Clin Pract; 2006 Oct; 74(1):103-9. PubMed ID: 16621114
[TBL] [Abstract][Full Text] [Related]
4. The impact of site and extent of clinically evident cardiovascular disease and atherosclerotic burden on new cardiovascular events in patients with Type 2 diabetes. The SMART study.
Gorter PM; Visseren FL; Algra A; van der Graaf Y;
Diabet Med; 2007 Dec; 24(12):1352-60. PubMed ID: 18042079
[TBL] [Abstract][Full Text] [Related]
5. Reduced GFR and microalbuminuria are independently associated with prevalent cardiovascular disease in Type 2 diabetes: JDDM study 16.
Yokoyama H; Oishi M; Kawai K; Sone H;
Diabet Med; 2008 Dec; 25(12):1426-32. PubMed ID: 19046241
[TBL] [Abstract][Full Text] [Related]
6. Effect of metabolic syndrome or type II diabetes mellitus on the occurrence of recurrent vascular events in hypertensive patients.
Vlek AL; van der Graaf Y; Spiering W; Visseren FL;
J Hum Hypertens; 2008 May; 22(5):358-65. PubMed ID: 18273039
[TBL] [Abstract][Full Text] [Related]
7. Triglyceride, albuminuria and blood pressure are the major associations of non-fatal cardiovascular disease in Chinese type 2 diabetes.
Ko GT; Chan JC; Chow CC; Yeung VT; Chan WB; So WY; Ma RC; Ozaki R; Cockram CS
Acta Diabetol; 2003 Jun; 40(2):80-4. PubMed ID: 12861405
[TBL] [Abstract][Full Text] [Related]
8. Normotensive women with type 2 diabetes and microalbuminuria are at high risk for macrovascular disease.
Zandbergen AA; Sijbrands EJ; Lamberts SW; Bootsma AH
Diabetes Care; 2006 Aug; 29(8):1851-5. PubMed ID: 16873791
[TBL] [Abstract][Full Text] [Related]
9. Patients with coronary, cerebrovascular or peripheral arterial obstructive disease differ in risk for new vascular events and mortality: the SMART study.
Achterberg S; Cramer MJ; Kappelle LJ; de Borst GJ; Visseren FL; van der Graaf Y; Algra A;
Eur J Cardiovasc Prev Rehabil; 2010 Aug; 17(4):424-30. PubMed ID: 20555265
[TBL] [Abstract][Full Text] [Related]
10. Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus.
Krane V; Winkler K; Drechsler C; Lilienthal J; März W; Wanner C;
Am J Kidney Dis; 2009 Nov; 54(5):902-11. PubMed ID: 19781835
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular autonomic dysfunction predicts acute ischaemic stroke in patients with Type 2 diabetes mellitus: a 7-year follow-up study.
Ko SH; Song KH; Park SA; Kim SR; Cha BY; Son HY; Moon KW; Yoo KD; Park YM; Cho JH; Yoon KH; Ahn YB
Diabet Med; 2008 Oct; 25(10):1171-7. PubMed ID: 19046195
[TBL] [Abstract][Full Text] [Related]
12. Microalbuminaria and the risk of atherosclerosis. Clinical epidemiological and physiological investigations.
Jensen JS
Dan Med Bull; 2000 Apr; 47(2):63-78. PubMed ID: 10822799
[TBL] [Abstract][Full Text] [Related]
13. Carotid intima-media thickness and the risk of new vascular events in patients with manifest atherosclerotic disease: the SMART study.
Dijk JM; van der Graaf Y; Bots ML; Grobbee DE; Algra A
Eur Heart J; 2006 Aug; 27(16):1971-8. PubMed ID: 16835264
[TBL] [Abstract][Full Text] [Related]
14. Mild renal insufficiency as a cardiovascular risk factor in non-proteinuric type II diabetes.
Gimeno-Orna JA; Lou-Arnal LM; Boned-Juliani B; Molinero-Herguedas E
Diabetes Res Clin Pract; 2004 Jun; 64(3):191-9. PubMed ID: 15126007
[TBL] [Abstract][Full Text] [Related]
15. Smoking as an independent risk factor for myocardial infarction or stroke in type 2 diabetes: a report from the Swedish National Diabetes Register.
Nilsson PM; Cederholm J; Eeg-Olofsson K; Eliasson B; Zethelius B; Fagard R; Gudbjörnsdóttir S;
Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):506-12. PubMed ID: 19561510
[TBL] [Abstract][Full Text] [Related]
16. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people.
Schramm TK; Gislason GH; Køber L; Rasmussen S; Rasmussen JN; Abildstrøm SZ; Hansen ML; Folke F; Buch P; Madsen M; Vaag A; Torp-Pedersen C
Circulation; 2008 Apr; 117(15):1945-54. PubMed ID: 18378618
[TBL] [Abstract][Full Text] [Related]
17. Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation.
van Halm VP; Peters MJ; Voskuyl AE; Boers M; Lems WF; Visser M; Stehouwer CD; Spijkerman AM; Dekker JM; Nijpels G; Heine RJ; Bouter LM; Smulders YM; Dijkmans BA; Nurmohamed MT
Ann Rheum Dis; 2009 Sep; 68(9):1395-400. PubMed ID: 18697775
[TBL] [Abstract][Full Text] [Related]
18. C-reactive protein is a strong independent predictor of death in type 2 diabetes: association with multiple facets of the metabolic syndrome.
Linnemann B; Voigt W; Nobel W; Janka HU
Exp Clin Endocrinol Diabetes; 2006 Mar; 114(3):127-34. PubMed ID: 16636979
[TBL] [Abstract][Full Text] [Related]
19. Ability of retinopathy to predict cardiovascular disease in patients with type 2 diabetes mellitus.
Gimeno-Orna JA; Faure-Nogueras E; Castro-Alonso FJ; Boned-Juliani B
Am J Cardiol; 2009 May; 103(10):1364-7. PubMed ID: 19427429
[TBL] [Abstract][Full Text] [Related]
20. Role of cytomegalovirus sero-status in the development of secondary cardiovascular events in patients with coronary heart disease under special consideration of diabetes.
Guech-Ongey M; Brenner H; Twardella D; Hahmann H; Rothenbacher D
Int J Cardiol; 2006 Jul; 111(1):98-103. PubMed ID: 16229909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
